Tirzepatide Online: Getting Zepbound Legally, With Prices
How to get tirzepatide online legally: Lilly self-pay, a telehealth prescription filled by a licensed pharmacy, or compounding, with prices as of 3 October 2026.
The short version
You can get tirzepatide online legally, but only with a prescription. As of 3 October 2026, Lilly sells Zepbound vials and KwikPens straight to self-pay patients for $299 to $449 a month, with refills within 45 days. A licensed prescriber, including a telehealth one, can also send a prescription to a licensed pharmacy. Compounded tirzepatide is not FDA-approved and is now tightly limited. A vial sold online as a research peptide is not a legal way to get it.
- Every legal route needs a prescription from a prescriber licensed in the state where you are.
- Lilly's self-pay Zepbound: $299 (2.5 mg), $399 (5 mg), and $449 from 7.5 mg with refills within 45 days.
- With commercial insurance that covers Zepbound, the savings card can cut a fill to $25; Medicare Part D members may pay $50.
- FDA has warned sellers of tirzepatide labelled "for research purposes" that are sold to consumers with dosing instructions.
You can get tirzepatide online legally, but only with a prescription. As of 3 October 2026, Lilly sells Zepbound vials and KwikPens directly to self-pay patients for $299 to $449 a month, with refills within 45 days. A licensed prescriber, including a telehealth one, can also send a prescription to a licensed pharmacy.
A vial sold online as a “research” peptide, with no prescription, is not a legal way to get tirzepatide and is not the same product.
Three legal routes to tirzepatide online
1. Lilly self-pay (LillyDirect). Lilly sells Zepbound vials and KwikPens directly to cash-paying patients, and manages Zepbound vial orders through LillyDirect. Mounjaro, the diabetes brand, is also available self-pay through LillyDirect. You still need a prescription from your own doctor or a telehealth prescriber.
2. A prescriber plus a licensed pharmacy. A doctor, nurse practitioner or physician associate prescribes Zepbound or Mounjaro, in person or by telehealth, and a licensed retail or mail-order pharmacy fills it. This is the route that can use insurance or a manufacturer savings card. The prescriber generally has to be licensed in the state where you are at the time of the consult. See peptide telehealth for what a real consult involves.
3. Compounded tirzepatide (narrow). A state-licensed 503A pharmacy can compound tirzepatide for an individual patient’s prescription. The product is not FDA-approved, and the rules have tightened.
- FDA’s shortage-era enforcement discretion for tirzepatide had ended for both 503A pharmacies and 503B outsourcing facilities by 19 March 2025.
- Tirzepatide is not on FDA’s shortage list or its 503B bulks list, so outsourcing facilities may not compound it from bulk ingredients.
- FDA treats a compounded product as “essentially a copy” of Zepbound if it has the same ingredient, a similar strength and the same route. The exception is a prescriber documenting a significant difference for that patient.
- FDA says it does not intend to act against a pharmacy that fills four or fewer prescriptions of such a copy in a calendar month.
- On 6 February 2026, FDA said it intends to restrict the GLP-1 ingredients used in mass-marketed compounded copies. On 3 March 2026 it announced warning letters to 30 telehealth companies over claims that compounded GLP-1s are the same as approved drugs.
Tirzepatide prices online (3 October 2026)
Lilly self-pay prices for a Zepbound vial or KwikPen, one month = 28 days:
| Dose | Regular self-pay price | First fill or refill within 45 days |
|---|---|---|
| 2.5 mg | $299 | $299 |
| 5 mg | $399 | $399 |
| 7.5 mg | $499 | $449 |
| 10, 12.5 or 15 mg | $699 | $449 |
The $449 price applies to the first fill at 7.5 mg or above and to refills within 45 days. Lilly’s savings page states it for the KwikPen, and TrumpRx lists the same $449 for vials.
Other ways to pay:
| Product or programme | Price | Conditions |
|---|---|---|
| Zepbound single-dose pen, savings card | $25 per fill | Commercial insurance that covers it; savings capped at $100 a month and $1,300 a year; card ends 31 December 2026 |
| Zepbound single-dose pen, savings card | $499 a month | Commercial insurance that does not cover it |
| Mounjaro single-dose pens | $499 per one-month fill | Self-pay, listed on TrumpRx, orders through LillyDirect |
| Mounjaro savings card | $25 per fill | Commercial insurance that covers it; savings capped at $150 a month |
| Medicare GLP-1 Bridge | $50 a month | Medicare Part D, Zepbound KwikPen only, for weight management; eligibility rules apply |
| Zepbound KwikPen at Costco | $499.22 (2.5 to 7.5 mg), $699.21 (10 to 15 mg) | Member price, warehouse pick-up; I could not confirm whether Lilly’s offer applies there |
Lilly’s savings cards exclude Medicare, Medicaid and other government plans. Lilly also says coverage has been restored on select CVS Caremark formularies, starting at $25 a month. Most insured patients do not pay the list price, which is $499 to $1,086.37 per fill for Zepbound and $1,112.16 for Mounjaro. For semaglutide and the full comparison, see cheapest tirzepatide and semaglutide.
FDA’s red flags for online sellers
FDA publishes warning signs for online and telehealth sellers of GLP-1 drugs. Be wary of a seller that:
- Claims a compounded drug is the same as an FDA-approved one.
- Offers deep discounts or prices that seem too good to be true.
- Sends medicine that looks different from before, or arrives damaged.
- Does not require screening and a prescription by a licensed doctor.
- Has no licensed doctor available to answer questions afterwards.
- Has spelling errors on the label or an incorrect pharmacy address.
- Uses a pharmacy name that looks fraudulent.
FDA warns that tirzepatide and semaglutide sold illegally online may be counterfeit, or contain the wrong ingredient or the wrong amount. It advises getting a prescription from your doctor and filling it at a state-licensed pharmacy.
Why a “research” tirzepatide vial is not Zepbound
Websites selling “research” tirzepatide are not a fourth route. FDA has warned companies that illegally sold unapproved drugs containing tirzepatide, semaglutide, retatrutide and other GLP-1s, falsely labelled “for research purposes” or “not for human consumption”. FDA says these were sold directly to consumers for human use, with dosing instructions.
Such a vial differs from Zepbound in three ways that matter for safety:
- No drug approval. No regulator has reviewed how it is made, what is in it or how much.
- No prescriber. No one screens for the conditions that rule tirzepatide out, such as a family history of medullary thyroid cancer.
- No pharmacy. No licensed pharmacist checks the product, its storage or its label.
For what a certificate of analysis can and cannot show, see how to read a peptide COA. For the legal side, see research peptides and the law.
Related
- Cheapest tirzepatide and semaglutide: compounded vs branded cost
- Semaglutide online: getting Wegovy or Ozempic legally
- Best GLP-1 for weight loss: the approved options compared
- What is Zepbound?
- Tirzepatide: the approved label
- Tirzepatide dosage
- Tirzepatide pills: why there is no approved one
- Where to buy tirzepatide: every route, with prices
- Compounded tirzepatide dosage chart
- Peptide telehealth: how legal prescribing works
Common questions
Can you buy tirzepatide online legally?
Yes, with a prescription. Lilly sells Zepbound vials and KwikPens directly to self-pay patients, and a licensed prescriber, including a telehealth one, can send a prescription to a licensed pharmacy that delivers. Buying tirzepatide without a prescription, or as a research chemical, is not legal for human use.
What is the price of Eli Lilly tirzepatide?
As of 3 October 2026, Lilly's self-pay price for a Zepbound vial or KwikPen is $299 a month at 2.5 mg and $399 at 5 mg. At 7.5 mg to 15 mg it is $449 when each refill comes within 45 days, otherwise $499 (7.5 mg) or $699 (10 to 15 mg). Mounjaro, the diabetes brand, is $499 for a one-month fill on TrumpRx. Lilly's list price is $499 to $1,086.37 per fill for Zepbound and $1,112.16 for Mounjaro.
Can I get Zepbound online?
Yes, with a prescription. Lilly sells Zepbound vials and KwikPens to self-pay patients through LillyDirect, and telehealth prescribers can prescribe it after a real consult. The prescriber must be licensed in the state where you are, and the medicine should come from a licensed pharmacy.
Can you buy tirzepatide without a prescription?
Not legally in the US. Zepbound and Mounjaro are prescription-only, and FDA's advice is to get a prescription from your doctor and fill it at a state-licensed pharmacy. A seller offering tirzepatide with no prescription and no clinician screening matches one of FDA's own red flags.
Is there a generic tirzepatide?
I found none. FDA's Drugs@FDA database lists two tirzepatide applications, both held by Eli Lilly: Mounjaro and Zepbound (checked 3 October 2026). Compounded tirzepatide is not a generic. It is not FDA-approved, and FDA says sellers may not call compounded GLP-1 drugs generic versions of approved ones.
Is compounded tirzepatide legal?
Only in narrow cases. FDA's shortage-era allowance for compounding tirzepatide ended in early 2025. A 503A pharmacy may still compound for an individual patient. FDA treats a similar-strength injectable as a copy of Zepbound unless a prescriber documents a significant difference for that patient. It says it does not intend to act against a pharmacy filling four or fewer such copies a month. In February 2026 FDA said it intends to restrict the ingredients used in mass-marketed compounded GLP-1 drugs.
Is research tirzepatide the same as Zepbound?
No. A vial sold as research tirzepatide is not made, tested or labelled as a medicine, and comes with no prescriber and no pharmacy. FDA has warned companies that illegally sold tirzepatide and other GLP-1 drugs directly to consumers, with dosing instructions, labelled for research purposes or not for human consumption.
What are the possible side effects of taking tirzepatide?
Stomach side effects are the most common. In the Zepbound trials, nausea affected 25% to 29% across doses against 8% on placebo, diarrhoea 19% to 23% against 8%, and vomiting 8% to 13% against 2%. The label carries a boxed warning about thyroid C-cell tumours seen in rats. Zepbound should not be used with a personal or family history of medullary thyroid cancer or MEN 2.
How do I check an online tirzepatide seller?
I do not rank sellers. Check that a licensed clinician screens you before prescribing. Check that the prescription is for Zepbound, Mounjaro or a compounded drug from a named licensed pharmacy, and that a clinician is available afterwards. FDA warns against sellers that claim a compounded drug is the same as an approved one. It also warns against prices that seem too good to be true and medicine that looks different or arrives damaged.
References (14 sources)
Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.
- 1.Lilly pricing information for Zepbound: list price range per fill and direct-to-patient self-pay prices by dose for vials and KwikPens (checked 3 October 2026).- Eli Lilly and Companyother
- 2.Zepbound savings and self-pay page: $449 KwikPen offer with refills within 45 days, regular prices, savings card terms, CVS Caremark coverage and the Medicare GLP-1 Bridge (checked 3 October 2026).- Eli Lilly and Companyother
- 3.Lilly pricing information for Mounjaro: list price per fill and the LillyDirect self-pay route (checked 3 October 2026).- Eli Lilly and Companyother
- 4.Mounjaro savings and coverage page: savings card terms and LillyDirect self-pay availability (checked 3 October 2026).- Eli Lilly and Companyother
- 5.TrumpRx listing for Zepbound vials: per-strength self-pay prices, orders managed through LillyDirect (checked 3 October 2026).- TrumpRx.gov (US government)database
- 6.TrumpRx listing for Mounjaro single-dose pens: $499 out-of-pocket price at every strength, against a $1,112.16 list price, orders through LillyDirect (checked 3 October 2026).- TrumpRx.gov (US government)database
- 7.Costco Pharmacy member price for the Zepbound KwikPen by strength, warehouse pick-up and home delivery (checked 3 October 2026).- Costco Pharmacyother
- 8.Medicare.gov - weight loss drugs: the Medicare GLP-1 Bridge covers the Zepbound KwikPen (not vials or single-dose pens) from 1 July 2026, with a $50 monthly copay.- Centers for Medicare & Medicaid Servicesregulatory
- 9.ZEPBOUND (tirzepatide) prescribing information: indications, dosage forms, adverse reaction rates, boxed warning and contraindications.- DailyMed, National Library of Medicinelabel
- 10.openFDA Drugs@FDA query for tirzepatide: two applications, both Eli Lilly NDAs (Mounjaro and Zepbound), checked 3 October 2026.- US Food and Drug Administrationdatabase
- 11.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (updated 1 October 2026): telehealth red flags, illegal online sales, research-labelled GLP-1 products, and where to fill a prescription.- US Food and Drug Administrationregulatory
- 12.FDA - FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (updated 1 April 2026): end of enforcement discretion, essentially-a-copy test, four prescriptions a month, 503B limits.- US Food and Drug Administrationregulatory
- 13.FDA news release, 6 February 2026: FDA intends to restrict GLP-1 ingredients used in mass-marketed non-approved compounded drugs, and limits marketing claims.- US Food and Drug Administrationregulatory
- 14.FDA news release, 3 March 2026: warning letters to 30 telehealth companies over claims of sameness and obscured sourcing for compounded GLP-1 drugs.- US Food and Drug Administrationregulatory